The future of transporting medicines lies in these containers. The port of Antwerp in Belgium is emerging as a key logistics hub for Novartis.
We aim to bring a mentality of sustainability across all of our operations,” says Steffen Lang, Global Head Technical Operations, who is overseeing the company’s sprawling production network. “That includes not only our own production, but also every step between sourcing our starting materials and when a patient uses one of our medicines – and all of our supply chain partners along the way as well.”
In 2018, Novartis committed to making its internal operations carbon-neutral by 2025, as well as reducing plastic waste and eliminating any water quality impacts from manufacturing effluents. With an eye on both local and global operations, Novartis, among others, has recently joined the Environmental League of Massachusetts Corporate Council as well as urging the US government, along with other companies, to back the Paris Agreement.
The 2030 targets are even more ambitious – becoming plastic- and water-neutral, and reducing the carbon footprint of the entire supply chain. Beyond how Novartis powers its own facilities, the 2030 targets seek to reduce the footprint of all business-related travel, supply shipments and also how the supply chain partners source their own energy. This requires working together with a very wide range of suppliers around the world – each in countries with different regulations, requirements and infrastructure.
Besides NTO’s massive efforts and due to the sheer complexity of the endeavor, many other parts of the organization are involved in the process too, including Health, Safety and Environment (HSE), which is directly liaising with suppliers to educate them about their energy-saving possibilities.
“What we’re trying to achieve next is that our partners think about our targets and the opportunities we can help them materialize – and to turn this into a success for them as well,” says Daniela Kessle, who heads the HSE efforts in this respect as Head of Supplier Assurance and Risk.